Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 339 páginas
Examen

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE 4TH EDITION BY VIRGINA POOLE ARCANGELO

Document preview thumbnail
Vista previa 4 fuera de 339 páginas

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE 4TH EDITION BY VIRGINA POOLE ARCANGELO Product Description Pharmacotherapeutics for Advanced Practice: A Practical Approach 4th Edition Test Bank ISBN-10:6 ISBN-13:9968 Multiple choice questions (T/F, MCQ, Short Questions, Essays, …). ALL CHAPTERS AVAILABLE Test bank is what most professors use a reference when making exams for their students, which means there is a very high chance that you will see a very similar, if not the exact question in the test! Table of Contents UNIT 1 Principles of Therapeutics Chapter 1 Issues for the Practitioner in Drug Therapy Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Chapter 4 Principles of Pharmacotherapy in Pediatrics Chapter 5 Principles of Pharmacotherapy in Pregnancy and Lactation Chapter 6 Pharmacotherapy Principles in Older Adults Chapter 7 Principles of Pharmacology in Pain Management Chapter 8 Principles of Antimicrobial Therapy Chapter 9 Complementary and Alternative Medicine Chapter 10 Pharmacogenomics UNIT 2 Pharmacotherapy for Skin Disorders Chapter 11 Contact Dermatitis Chapter 12 Fungal Infections of the Skin Chapter 13 Viral Infections of the Skin Chapter 14 Bacterial Infections of the Skin Chapter 15 Psoriasis Chapter 16 Acne Vulgaris and Rosacea UNIT 3 Pharmacotherapy for Eye and Ear Disorders Chapter 17 Ophthalmic Disorders Chapter 18 Otitis Media and Otitis Externa UNIT 4 Pharmacotherapy for Cardiovascular Disorders Chapter 19 Hypertension Chapter 20 Hyperlipidemia Chapter 21 Chronic Stable Angina Chapter 22 Heart Failure Chapter 23 Arrhythmias UNIT 5 Pharmacotherapy for Respiratory Disorders Chapter 24 Upper Respiratory Infections Chapter 25 Asthma Chapter 26 Chronic Obstructive Pulmonary Disease Chapter 27 Bronchitis and Pneumonia UNIT 6 Pharmacotherapy for Gastrointestinal Tract Disorders Chapter 28 Nausea and Vomiting Chapter 29 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter 30 Constipation, Diarrhea, and Irritable Bowel Syndrome Chapter 31 Inflammatory Bowel Disease UNIT 7 Pharmacotherapy for Genitourinary Tract Disorders Chapter 32 Urinary Tract Infection Chapter 33 Prostatic Disorders and Erectile Dysfunction Chapter 34 Overactive Bladder Chapter 35 Sexually Transmitted Infections UNIT 8 Pharmacotherapy for Musculoskeletal Disorders Chapter 36 Osteoarthritis and Gout Chapter 37 Rheumatoid Arthritis UNIT 9 Pharmacology for Neurological/Psychological Disorders Chapter 38 Headaches Chapter 39 Seizure Disorders Chapter 40 Major Depressive Disorder Chapter 41 Anxiety Disorders Chapter 42 Insomnia and Sleep Disorders Chapter 43 Attention Deficit Hyperactivity Disorder Chapter 44 Alzheimer Disease Chapter 45 Parkinson Disease UNIT 10 Pharmacotherapy for Endocrine Disorders Chapter 46 Diabetes Mellitus Chapter 47 Thyroid Disorders UNIT 11 Pharmacotherapy for Immune Disorders Chapter 48 Allergies and Allergic Reactions Chapter 49 Human Immunodeficiency Virus UNIT 12 Pharmacotherapy for Hematologic Disorders Chapter 50 Pharmacotherapy for Venous Thromboembolism Prevention and Treatment, Stroke Prevention in Atrial Fibrillation, and Thromboembolism Prevention with Mechanical Heart Valves Chapter 51 Anemias UNIT 13 Pharmacotherapy in Health Promotion Chapter 52 Immunizations Chapter 53 Smoking Cessation Chapter 54 Weight Loss UNIT 14 Women’s Health Chapter 55 Contraception Chapter 56 Menopause Chapter 57 Osteoporosis Chapter 58 Vaginitis UNIT 15 Integrative Approach to Patient Care Chapter 59 The Economics of Pharmacotherapeutics Chapter 60 Integrative Approaches to Pharmacotherapy—A Look at Complex Cases

Vista previa del contenido

Stuvia.com dd- ddThe ddMarketplace ddto ddBuy ddand ddSell ddyour ddStudy ddMaterial




TEST BANK FOR PHARMACOTHERAPEUTICS FOR A
o o o o o



DVANCED PRACTICE-
dd o



A PRACTICAL APPROACH 5TH EDITION ARCANGE
o o o o o o



LO ALL CHAPTERS INCLUDED|| LATEST AND COMP
o o o o o o



LETE UPDATE 2025 WITH VERIFIED SOLUTIONS|| G
dd o o o o o o



U ARANTEED A+
dd o

, Stuvia.com
Stuvia.com
dd- ddThe
- The
ddMarketplace
Marketplaceddto
toddBuy ddand
andSell
ddSell
your
ddyour
Study
ddStudy
Material
ddMaterial




1 |oPoaogo e
dd dd




TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCED PRACTI
o o o o o o


CE-
dd



A PRACTICAL APPROACH 5TH EDITION ARCANGELO ALL CHAPTERS I
o o o o o o o o o


NCLUDED|| LATEST AND COMPLETE UPDATE 2025 WITH VERIFIED SO
o o o o o o o o


LUTIONS|| GUARANTEED A+
dd o o




Pharmacology for Advanced Practice Nursing (Kennesaw State University)
o o o o o o o



Chapter 01: Issues for the Practitioner in Drug Therapy
o o dd o o o o o o




oMULTIPLE CHOICE o




1. Nurse practitioner prescriptive authority is regulated by:
o o o o o o




A. The National Council of State Boards of Nursing
o o o o o o o




B. The U.S. Drug Enforcement Administration
o o o o




C. The State Board of Nursing for each state
o o o o o o o



D. The State Board of Pharmacy
o o o o




ANSWER- C o PTS: 1 o




2. Physician Assistant (PA) prescriptive authority is regulated by:
o o o o o o o



A. The National Council of State Boards of Nursing
o o o o o o o




B. The U.S. Drug Enforcement Administration
o o o o




C. The State Board of Nursing
o o o o



D. The State Board of Medical Examiners
o o o o o




ANSWER- D o PTS: 1 o




3. Clinical judgment in prescribing includes:
o o o o



A. Factoring in the cost to the patient of the medication prescribed
o o o o o o o o o o




B. Always prescribing the newest medication available for the disease process
o o o o o o o o o

, Stuvia.com
Stuvia.com
dd- ddThe
- The
ddMarketplace
Marketplaceddto
toddBuy ddand
andSell
ddSell
your
ddyour
Study
ddStudy
Material
ddMaterial




2 |oPoaogo e
dd dd




C. Handing out drug samples to poor patients
o o o o o o




D. Prescribing all generic medications to cut costs
o o o o o o



ANSWER- A o PTS: 1 o




4. Criteria for choosing an effective drug for a disorder include:
o o o o o o o o o




A. Asking the patient what drug they think would work best for them
o o o o o o o o o o o



B. Consulting nationally recognized guidelines for disease management
o o o o o o




C. Prescribing medications that are available as samples before writing a p
o o o o o o o o o o


rescription
dd




D. Following U.S. Drug Enforcement Administration (DEA) guidelines for p
o o o o o o o o


rescribing
dd




ANSWER- B o PTS: 1 o




5. Nurse practitioner practice may thrive under health-care reform due to:
o o o o o o o o o



A. The demonstrated ability of nurse practitioners to control costs and improve p
o o o o o o o o o o o


atient outcomes
dd o




B. The fact that nurse practitioners will be able to practice independently
o o o o o o o o o o




C. The fact that nurse practitioners will have full reimbursement under health-
o o o o o o o o o o


care reform
o o



D. The ability to shift accountability for Medicaid to the state level
o o o o o o o o o o




ANSWER- A o PTS: 1 o

, Stuvia.com
Stuvia.com
dd- ddThe
- The
ddMarketplace
Marketplaceddto
toddBuy ddand
andSell
ddSell
your
ddyour
Study
ddStudy
Material
ddMaterial




3 |oPoaogo e
dd dd




Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic MU
o o o o o o o o




LTIPLE CHOICE
dd o




1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This is cr
o o o o o o o o o o o


itical to prescribing because:
dd o o o




A. Distribution of drugs to target tissue may be affected
o o o o o o o o




B. The solubility of the drug will not match the site of absorption
o o o o o o o o o o o




C. There will be less free drug available to generate an effect
o o o o o o o o o o



D. Drugs bound to albumin are readily excreted by the kidney
o o o o o o o o o




ANSWER- A o PTS: 1 o




2. Drugs that have a significant first-pass effect:
o o o o o o




A. Must be given by the enteral (oral) route only
o o o o o o o o




B. Bypass the hepatic circulation
o o o




C. Are rapidly metabolized by the liver and may have little if any desired action
o o o o o o o o o o o o o




D. Are converted by the liver to more active and fat-soluble forms
o o o o o o o o o o



ANSWER- C o PTS: 1 o




3. The route of excretion of a volatile drug will likely be:
o o o o o o o o o o

Libro relacionado
 image
Virginia Poole Arcangelo, Andrew M. Peterson, Veronica Wilbur Pharmacotherapeutics for Advanced Practice
Editorial: 2016 ISBN: 9781496319968 Edición: Desconocido

Información del documento

Subido en
18 de agosto de 2026
Número de páginas
339
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$16.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
64
Última venta
-



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes